- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/40 - CyclodextrinsDerivatives thereof
Patent holdings for IPC class A61K 47/40
Total number of patents in this class: 2041
10-year publication summary
|
127
|
147
|
190
|
196
|
212
|
168
|
167
|
171
|
139
|
39
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Axsome Therapeutics, Inc. | 323 |
102 |
| CyDex Pharmaceuticals, Inc. | 106 |
50 |
| Oculis Operations Sàrl | 41 |
20 |
| The Regents of the University of California | 20473 |
17 |
| Pfizer Inc. | 3353 |
17 |
| Aldeyra Therapeutics, Inc. | 103 |
17 |
| Massachusetts Institute of Technology | 10192 |
15 |
| Novartis AG | 10376 |
14 |
| The Brigham and Women's Hospital, Inc. | 2249 |
14 |
| Roquette Freres | 1039 |
14 |
| Yale University | 2474 |
12 |
| Cardioxyl Pharmaceuticals, Inc. | 46 |
11 |
| Boehringer Ingelheim Vetmedica GmbH | 1272 |
10 |
| Allergan, Inc. | 2225 |
10 |
| Hikma Pharmaceuticals USA Inc. | 150 |
10 |
| Faes Farma, S.A. | 104 |
9 |
| Aardvark Therapeutics Inc. | 52 |
9 |
| Oncopeptides Innovation AB | 28 |
9 |
| Sage Therapeutics, Inc. | 337 |
8 |
| Sapiotec GmbH | 18 |
8 |
| Other owners | 1665 |